In the European region Countries like Italy, Spain, the UK, Germany, France, and other European counties such as Russia, Switzerland are highly affected. The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most affected European countries and number of deaths are also high. The current coronavirus (COVID-19) outbreak has been declared by WHO as a Public Health Emergency of International Concern, according to the International Health Regulation. Biobanks have been helpful in the fight against Covid-19 because they have provided researchers with access to the samples, they need to explore the disease and create vaccines and therapies. While the pandemic posed a significant problem for biobanks, it also gave an opportunity for future growth in many other areas of research. It would have been impossible to make the genome of the SARS-CoV-2 virus accessible to the whole scientific community and produce efficient vaccinations in record time without samples from patients infected with Covid-19. Since the beginning of the pandemic, researchers have been requesting these samples to undertake tests to better understand the virus's various mechanisms for tricking human immune systems.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe biobanks market. The Europe biobanks market is expected to grow at a good CAGR during the forecast period.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 699.13 Million |
| Market Size by 2028 | US$ 1,070.46 Million |
| CAGR (2021 - 2028) | 6.3% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product and Service
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
The Europe Biobanks Market is valued at US$ 699.13 Million in 2021, it is projected to reach US$ 1,070.46 Million by 2028.
As per our report Europe Biobanks Market, the market size is valued at US$ 699.13 Million in 2021, projecting it to reach US$ 1,070.46 Million by 2028. This translates to a CAGR of approximately 6.3% during the forecast period.
The Europe Biobanks Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Biobanks Market report:
The Europe Biobanks Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Biobanks Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Biobanks Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Biobanks Market
